PHBI vs MRK: Which Stock is Better?
Side-by-side comparison of Pharmagreen Biotech Inc. and Merck & Co Inc in 2026
PHBI
Pharmagreen Biotech Inc.
$0.00
MRK
Merck & Co Inc
$119.07
Key Metrics Comparison
| Metric | PHBI | MRK | Winner |
|---|---|---|---|
| Market Cap | $0.83M | $294.39B | MRK |
| P/E Ratio | N/A | 16.36 | MRK |
| EPS (TTM) | $N/A | $7.28 | MRK |
| Revenue Growth | -0.3% | 0.1% | MRK |
| Gross Margin | 44.9% | 77.2% | MRK |
Analyze PHBI
Full quant analysis
Analyze MRK
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PHBI or MRK a better investment?
Comparing PHBI and MRK: Pharmagreen Biotech Inc. has a market cap of $0.83M while Merck & Co Inc has $294.39B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PHBI and MRK?
PHBI (Pharmagreen Biotech Inc.) and MRK (Merck & Co Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PHBI or MRK?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PHBI or MRK?
MRK has higher revenue growth at 0.1% vs -0.3% for PHBI.
Which company is more profitable: PHBI or MRK?
Merck & Co Inc (MRK) has higher gross margins at 77.2% compared to 44.9% for PHBI.
Which is the larger company: PHBI or MRK?
Merck & Co Inc (MRK) is larger with a market cap of $294.39B compared to $0.83M for PHBI.
Should I buy PHBI or MRK in 2026?
Both PHBI and MRK have investment merit. PHBI trades at $0.00 while MRK trades at $119.07. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PHBI and MRK stock?
Key differences: Market Cap ($0.83M vs $294.39B), P/E Ratio (N/A vs 16.4x), Revenue Growth (-0.3% vs 0.1%), Gross Margin (44.9% vs 77.2%).